PT  - JOURNAL ARTICLE
AU  - Paredes, Jan A.
AU  - Garduño, Valeria
AU  - Torres, Julian
TI  - COVID-19 Related Mortality: Is the BCG Vaccine Truly Effective?
AID  - 10.1101/2020.05.01.20087411
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.01.20087411
4099  - http://medrxiv.org/content/early/2020/05/06/2020.05.01.20087411.short
4100  - http://medrxiv.org/content/early/2020/05/06/2020.05.01.20087411.full
AB  - The coronavirus disease 2019 (COVID-19) pandemic has become a worldwide emergency. In the attempt to search for interventions that would improve outcomes, some studies have looked at the potential benefit of BCG vaccination. These past studies have found a statistically significant reduction in COVID-19 related mortality in countries with a current universal bacille Calmette-Guérin (BCG) vaccination policy. However, just as the authors themselves noted, the nature of ecological studies make them very prone to the presence of several confounders. This paper took into account demographic differences, economic differences and the different stages of the pandemic in each country; gathering data from publicly available sources. It was found that no statistically significant difference exists in mortality rates between countries with a current or prior BCG vaccination policy when compared to those that never had such a program. Nevertheless, the immunostimulatory potential of the BCG vaccine might still prove useful in the development of future vaccines or other prophylactic measures.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no specific funding for this work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are within the manuscript and its Supporting Information files. http://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups http://www.bcgatlas.org https://www.worldometers.info/coronavirus/coronavirus-cases/